The effects of tolvaptan on patients with severe chronic kidney disease complicated by congestive heart failure

Overview of attention for article published in Clinical and Experimental Nephrology, March 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#30 of 769)
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 1 news outlet

twitter: 4 X users

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 51 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 32,209 followers.

RT @edgarvlermamd: VAPTANS for CKD in CHF⁉ #Nephpearls @kidney_boy @NephroMD https://t.co/I2LZ0Q0r7M https://t.co/AhmN2vkfYq

Reply Repost Favourite

RT @edgarvlermamd: VAPTANS for CKD in CHF⁉ #Nephpearls @kidney_boy @NephroMD https://t.co/I2LZ0Q0r7M https://t.co/AhmN2vkfYq

Reply Repost Favourite

RT @edgarvlermamd: VAPTANS for CKD in CHF⁉ #Nephpearls @kidney_boy @NephroMD https://t.co/I2LZ0Q0r7M https://t.co/AhmN2vkfYq

Reply Repost Favourite

VAPTANS for CKD in CHF⁉ #Nephpearls @kidney_boy @NephroMD https://t.co/I2LZ0Q0r7M https://t.co/AhmN2vkfYq

Reply Repost Favourite